Handok to launch Tritace Protect.

Handok launched a cardiovascular protective drug called "Tritace Protect" (ramipril 10mg) in to the Korean market, which was earlier proven of its therapeutic benefits through the studies of "HOPE: heart outcomes prevention evaluation" and "HOPE TOO: the ongoing outcomes". So far Tritace 2.5mg and 5mg have been available in the market.

The company said that Tritace protect showed a risk redu...